Both genetic loss-of-KLF4 in the NOTCH1-induced T-ALL mouse model or epigenetic KLF4 inactivation via CpG methylation in children with T-ALL caused aberrant activation of MAP2K7 and the downstream target JNK [9, 14, 35, 36]. Here, KLF4 is linked to acute lymphoblastic leukemia.